“There are likely to have been 15 times more suicides on antidepressant drugs than reported by the FDA in its meta-analysis of 100,000 patients in 2006,” writes Prof. Peter C. Gotzsche, MD in Chapter 16 What can patients do? of his excellent book Deadly Psychiatry and Organised Denial.
“There were only five suicides in FDA’s analysis of 52,960 patients on SSRIs (one per 10,000 patients), but an internal Lilly memo from 1990 described nine suicides in 6,993 patients on fluoxetine in the trials (13 per 10,000).
“An analysis of prescriptions written by general practitioners in the UK immediately after the drugs came on market is similarly revealing. The patients had an average age of 50 and 79% had depression, but although the follow-up was only about six months, there were 90 suicides among patients receiving fluoxetine, sertraline or paroxetine, which was 24, 17 and 27 suicides per 10,000, respectively.”
© Copyright 2003-2017 - Larry Hobbs - All Rights Reserved.